<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[TerriCare]]></title><description><![CDATA[TerriCare]]></description><link>https://www.terricare.net/blog</link><generator>RSS for Node</generator><lastBuildDate>Fri, 05 Jun 2026 02:02:04 GMT</lastBuildDate><atom:link href="https://www.terricare.net/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[GLP-1 Medications: The Real Reason We're Seeing More Adverse Events ]]></title><description><![CDATA[Introduction You may have seen recent reports suggesting a dramatic rise in adverse events and overdoses related to GLP-1 medications such as semaglutide and tirzepatide. Some headlines describe increases of over 1,000%. That number gets attention—but it requires context. Reported GLP-1 exposures by month (2025 YTD). Source: U.S. Poison Control Centers. What the Data Shows Reported exposures have increased—but these reflect calls and reports, not necessarily severe toxicity. GLP-1 exposure...]]></description><link>https://www.terricare.net/post/glp-1-medications-the-real-reason-we-re-seeing-more-adverse-events</link><guid isPermaLink="false">69fa2a705caf4ed272bd9aba</guid><pubDate>Tue, 05 May 2026 20:22:45 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d3b9f4_6210095d2066493a84a8ab45a3274b4d~mv2.jpeg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Terri Clawson</dc:creator></item></channel></rss>